Another diabetes drug scarce until end 2024

Eli Lilly’s Trulicity had been been ‘go-to’ replacement for in-demand Ozempic Trulicity, the type-2 diabetes preparation which had been a regular stop-gap option when the much-hyped Ozempic was in short supply, is now itself facing shortages until the end of 2024. The Lilly drug, with active ingredient dulaglutide, was frequently prescribed as a replacement during